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Background: Clinical outcomes of dialysis patients are variable, and improved knowledge of prognosis would
inform decisions regarding patient management. We assessed the value of simple, chest X-ray derived measures of
cardiac size (cardiothoracic ratio (CTR)) and vascular calcification (Aortic Arch Calcification (AAC)), in predicting death
and improving multivariable prognostic models in a prevalent cohort of hemodialysis patients.
Methods: Eight hundred and twenty-four dialysis patients with one or more postero-anterior (PA) chest X-ray were
included in the study. Using a validated calcification score, the AAC was graded from 0 to 3. Cox proportional
hazards models were used to assess the association between AAC score, CTR, and mortality. AAC was treated
as a categorical variable with 4 levels (0,1,2, or 3). Age, race, diabetes, and heart failure were adjusted for in the
multivariable analysis. The criterion for statistical significance was p<0.05.
Results: The median CTR of the sample was 0.53 [IQR=0.48,0.58] with calcification scores as follows: 0 (54%), 1
(24%), 2 (17%), and 3 (5%). Of 824 patients, 152 (18%) died during follow-up. Age, sex, race, duration of dialysis,
diabetes, heart failure, ischemic heart disease and baseline serum creatinine and phosphate were included in a base
Cox model. Both CTR (HR 1.78[1.40,2.27] per 0.1 unit change), area under the curve (AUC)=0.60[0.55,0.65], and AAC
(AAC 3 vs 0 HR 4.35[2.38,7.66], AAC 2 vs 0 HR 2.22[1.41,3.49], AAC 1 vs 0 HR 2.43[1.64,3.61]), AUC=0.63[0.58,0.68])
were associated with death in univariate Cox analysis. CTR remained significant after adjustment for base model
variables (adjusted HR 1.46[1.11,1.92]), but did not increase the AUC of the base model (0.71[0.66,0.76] vs. 0.71
[0.66,0.76]) and did not improve net reclassification performance (NRI=0). AAC also remained significant on
multivariable analysis, but did not improve net reclassification (NRI=0). All ranges were based on 95%
confidence intervals.
Conclusions: Neither CTR nor AAC assessed on chest x-ray improved prediction of mortality in this prevalent
cohort of dialysis patients. Our data do not support the clinical utility of X-ray measures of cardiac size and vascular
calcification for the purpose of mortality prediction in prevalent hemodialysis patients. More advanced imaging
techniques may be needed to improve prognostication in this population.
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Kidney failure is a major public health problem with
increasing incidence and prevalence worldwide [1]. Pa-
tients with kidney failure on dialysis experience poor over-
all survival, with an age and sex adjusted mortality several
fold higher than patients not on dialysis [2]. Although ag-
gregate survival on dialysis is poor, variability in individual
patient prognosis is substantial [3]. This poses significant
challenges for health care providers and patients alike.
Survival estimates are a crucial part of informed discus-
sions regarding starting or withdrawing from dialysis, and
often inform decisions regarding the intensity of screen-
ing, monitoring and treatment of comorbid diseases and
referral for kidney transplant [4-6]. Uncertainty about
these outcomes can render such decisions more difficult
for patients, families, and physicians.
In order to estimate survival, knowledge of risk factors is
essential. Mortality in dialysis is driven primarily by cardio-
vascular (CV) disease [7,8]. Consequently, major factors as-
sociated with cardiovascular disease on dialysis, such as left
ventricular hypertrophy (LVH) and coronary or aortic cal-
cification, are independent predictors of mortality and car-
diovascular events in dialysis patients [9,10]. However, the
high cost and unknown benefit of risk stratification based
on echocardiographic determination of LVH or CT scan-
ning for calcification precludes routine implementation for
the purposes of risk stratification in kidney failure [11].
Preliminary data suggest that measures obtained from a
routine posterior-anterior (PA) chest X-ray may provide
reasonable estimates of vascular calcification and left ven-
tricular size, and could enhance risk prediction without the
cost of a CT or echocardiogram [12,13].
Data in the general population has shown aortic arch
calcification (AAC) [14,15] and cardiothoracic ratio (CTR)
[16-18], both obtained from a routine chest X-ray, to be
predictors of CV outcome and mortality, respectively. The
prognostic value of these simple measurements has not
been studied in kidney failure, but if validated, chest X-ray
based measurements could be easily and cheaply im-
plemented with minimal inconvenience to patients and
improve risk stratification in the dialysis unit as part of
routine clinical care. In many hemodialysis units, chest
X-rays are routine for providing information for central
line placements, and surveillance for latent tuberculosis.
The objective of this study was to determine whether
chest X-ray derived measurements of cardiac size (CTR)
and vascular calcification (AAC score), could accurately
predict mortality and improve multivariable prognostic
models in patients with kidney failure.
Methods
Study population
The study was conducted in Winnipeg, Canada and was
approved by the research ethics board at the Universityof Manitoba. We performed a retrospective cohort study
utilizing a comprehensive prospective database of all
patients initiating dialysis in Manitoba Canada between
January 1, 2000 and August 1, 2010 (n = 2368). This
database is maintained by the Manitoba Renal Program
(MRP), which provides dialysis and chronic kidney dis-
ease services for the entire province of Manitoba and
areas of Northwestern Ontario (Catchment area appro-
ximately 1.5 million). Details of this database have been
described in previous studies [19]. Briefly, the database
captures patient demographics, cause of ESRD, comor-
bid conditions, type of dialysis, initial dialysis access,
initial blood work, modality transitions within the first
90 days, small molecule clearance, and outcomes such
as death, transplantation, or transfer out of province. All
new ESRD patients are reviewed in detail at a weekly
multidisciplinary team rounds and comorbid condi-
tions recorded in the database by dedicated MRP
personnel. All hospitalizations and deaths in the MRP
are reviewed and adjudicated weekly at the same team
rounds. A subset of this data is forwarded to the Canadian
Organ Replacement Register (CORR) maintained by the
Canadian Institute for Health Information. For the
purposes of the present analysis, we included only
adult (>18 years) chronic dialysis (on dialysis >90 days)
patients. We examined all-cause mortality as the pri-
mary outcome.
X-ray measurements
Eligible patients identified in the MRP database were
linked by PHIN (Personal Health Information Number)
and date of birth to a province-wide registry of radio-
graphic procedures (AGFA IMPAX 6) to identify chest
X-rays. Inclusion criteria were: initiation of dialysis in
Manitoba, Canada between January 1, 2000- Aug. 1,
2010, and the availability of a technically adequate
posterior-anterior chest X-ray between the period of
three months prior to the initiation of dialysis until
death or study end-date. The earliest available (i.e.
closest to date of dialysis initiation), technically ad-
equate chest X-ray was chosen for review. We defined
technical adequacy as a posterior-anterior chest X-ray
exhibiting defined heart borders and a defined aortic
knob. Thus, chest X-rays with severe effusions, infil-
trates, or anatomic or technique irregularities that
precluded identification of cardiothoracic ratio or aor-
tic arch calcification were excluded. Two adjudicators
independently assessed technical adequacy, with dis-
agreements resolved by consensus. Both film and
digital X-rays were included.
The grade of aortic arch calcification was assessed
using a previously validated scoring system: grade 0
(no visible calcification), grade 1 (small spots of calci-
fication or single thin calcification of the aortic knob),
A) B)
Figure 1 Clinical assessment of cardiothoracic ratio and aortic arch calcification. A) Measurement of cardiothoracic ratio (CTR). CTR is equal
to the maximal cardiac width divided by thoracic width, as shown. B) Assessment of aortic calcification using chest x-ray (lateral lumbar and
abdominal CT for comparison with calcification enclosed by white boxes), with examples of grade 0–3 shown. Permission pending for
reproduction of this image [12].
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and grade 3 (circular calcification of the aortic knob)
[20]. The cardiothoracic ratio was calculated as the
ratio of maximum transverse cardiac diameter in mil-
limeters to maximum thoracic diameter in millimeters.Figure 2 Process of patient exclusion from database.Both AAC grading and CTR measurement are illus-
trated in Figure 1. All measurements of AAC and
CTR were assessed independently by two adjudi-
cators, with disagreements resolved by a consensus
measurement.
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Summary statistics were presented as mean (standard
deviation (SD)) or median (25th, 75th centile) as appro-
priate; categorical values were described as proportions.
Univariable comparisons in patient characteristics were
performed with analysis of variance (ANOVA) or Chi
square test as appropriate.
Univariable Cox proportional hazards regression was
used to estimate the unadjusted impact of AAC grade
and CTR on all-cause mortality. For these analyses,
missing covariate values were imputed using multivari-
able imputation. In all cases, fewer than 8% of individual
covariate values were missing and therefore imputed.
Multivariable Cox Proportional Hazards Regression
models were constructed to 1) to identify a parsimoni-
ous base prediction model (best base model, BBM) using
clinical variables alone, 2) to assess whether AAC and
CTR were independent of these base model variables in
prediction of death, and 3) to calculate the improvement
in model discrimination and reclassification after addition
of AAC or CTR to the base model. CTR was treated as a
continuous variable, and AAC as a categorical variableTable 1 Characteristics of patients with and without an availa
Characteristics X-ray available
Proportion alive at end of follow-up 672/824
Age at dialysis start 57.3 [45.0, 68.1]











Hemoglobin (g/L) 93 [81, 106]
Creatinine (mcm/L) 678 [529, 876]
Urea (mmol/L) 31 [25, 40]
CO2 (mmol/L) 20 [16, 23]
Calcium (mmol/L) 2.1[1.8, 2.3]
PO4 (mmol/L) 2.1[1.7, 2.6]
Albumin (g/L) 29 [24, 34]
HD days at chest x-ray 463 [9, 1520]
Follow-up days 1173 [585, 2266]
Older Vintage (start year < 2005) 29%
Urban dialysis 83%with 4 levels (0, 1, 2, 3). The base prediction model for
death was built from a pool of candidate clinical variables
using both statistical and clinical significance; for the
purposes of this analysis, variables in the base models
were retained either if they were associated with a p < 0.1,
or based on known associations with mortality. Two
enriched models were created: base plus CTR, and base
plus AAC. We assessed model discrimination using Harrell’s
concordance statistic (C-statistic) and the integrated dis-
crimination improvement index (IDI). The Harrell’s C
statistic corresponds to the area under the receiver-
operating curve for the proportional hazards model, and
is the standard measure of discrimination. The IDI
measures the change in the discrimination slopes between
two alternative models, and is considered a more sensitive
measure of discrimination than the C-statistic. We also
examined model reclassification using the net reclassifica-
tion index, NRI [21]. NRI measures the ability of a new
model to correctly reclassify patients without the outcome
of interest (i.e. death) into lower risk categories and
patients with the outcome of interest into higher risk cat-
egories. For the purpose of the present analysis, we usedble chest X-Ray
X-ray not available p
444/800 <0.01











97 [84, 110] <0.01
632 [495, 815] <0.01
32 [24, 39] 0.93
20 [17, 24] 0.03
2.1 [1.8, 2.3] 0.97
2.0 [1.6, 2.5] 0.01
30 [25, 35] 0.01
N/A -
1112 [453, 1926] <0.01
30% 0.91
68% <0.01
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risk of death; moderate risk, 5-10% risk of death; and low
risk, <5% risk of death. To be judged clinically useful, the
models incorporating AAC and CTR had to exhibit sta-
tistically significant improvements in two of the following
three measures of predictive model performance: C-
statistic, IDI > 10%, and NRI > 10% [22,23]. All statistical
calculations were performed using IBM SPSS version 18.
Results
Of the initial 2368 potentially eligible patients, 824 had
technically adequate PA chest X-rays for the study and
were included in the analysis. The specific reasons for
exclusion are summarized in Figure 2.
Study population
The baseline characteristics of the study sample are
summarized in Table 1. Data on age, sex, diabetic status,
race, cause of renal disease, hemoglobin, serum creatin-
ine, serum calcium, serum phosphate, serum albumin,
other co-morbidities, and our primary outcome (all-
cause mortality) were obtained from the Manitoba Renal
Program database. The median age of the cohort was 60
[47, 71] years at the time of X-ray, with a median dialysisTable 2 Characteristics of X-rayed patients, alive and dead
Characteristics Alive
n 672/824











Hemoglobin (g/L) 93 [80, 106]
Creatinine (mcm.L) 709 [555, 892]
Urea (mmol/L) 31 [25, 39]
CO2 (mmol/L) 20 [16, 23]
Calcium (mmol/L) 2.1 [1.8, 2.3]
PO4 (mmol/L) 2.1 [1.7, 2.7]
Albumin (g/L) 29 [24, 34]
HD days at chest x-ray 401 [4.0, 1589]
Follow-up days 1257 [626, 2411]
Older Vintage (start year < 2005) 30%vintage of 1.3 years. Fifty-four percent of the cohort was
male, and 35% was of aboriginal descent.
Of the 824 patients, 152 patients died at a median
dialysis time of 2.5 years from initiation. Compared with
survivors, patients who died were significantly older
(68 years vs. 58 years, p < 0.01) at the chest X-ray date,
had a higher prevalence of CHF (22% vs. 14%, p = 0.01),
and had been on dialysis longer at the time of X-ray
assessment. Median serum creatinine at the start of
dialysis (566 vs. 709, p < 0.01) was lower in patients who
died (Table 2).
Median CTR for the cohort was 0.53 [0.48, 0.58],
and 67% had a CTR >0.5 (Table 3). The median CTR
in patients who died was higher than among survivors
(0.55 vs. 0.52, p < 0.01) and 79% had a CTR > 0.5.
Overall, 46% had AAC > 0, and among patients who
died that proportion rose to 64% vs. 41% in patients
who lived.
Comparison with missing data
To assess the possibility of a selection bias, we perfor-
med a sensitivity analysis comparing the characteristics
of patients with and without an available X-ray (Table 1).
On average, patients without X-rays were older, wereDead p
152/824 -










95 [85, 105] 0.26
566 [477, 723] <0.01
31 [23, 41] 0.91
20 [16, 23] 0.28
2.1 [1.8, 2.3] 0.32
2.1 [1.6, 2.5] 0.06
29 [24, 34] 0.94
608 [76, 1327] 0.61
912 [402, 1664] <0.01
28% 0.77
Table 3 Distribution of cardiothoracic ratio and aortic arch calcification grade across study population
Variable Overall (n = 824) Patients alive at end of
follow-up (n = 672)
Patients dead at end of
follow-up (n = 152)
p-value
Cardiothoracic ratio (CTR) 0.53 [0.48, 0.58] 0.52 [0.48, 0.57] 0.55 [0.51,0.59] <0.001
CTR > 0.5 67% (552/824) 64% (527/824) 79% (651/824) <0.001
Aortic arch calcification grade (%) <0.001
0 54% (445/824) 59% (394/672) 36% (54/152)
1 24% (198/824) 22% (146/672) 34% (52/152)
2 17% (140/824) 16% (107/672) 20% (30/152)
3 5% (41/824) 4% (25/672) 11% (16/152)
CTR =median [Q1, Q3].
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be of Caucasian descent. The study population had a
higher rate of diabetes than patients without X-rays, but
a lower rate of ischemic heart disease. Patients with
X-rays also had, on average, higher starting levels of cre-
atinine and phosphate, and lower levels of hemoglobin
and serum albumin.
Risk prediction for all cause mortality
Cardiothoracic ratio (per 0.1 unit change) and aortic arch
calcification were both significantly associated with death
on univariable proportional hazards analysis (Table 4).
Both variables remained statistically significant after multi-
variable adjustment (Table 5). However, the association
between AAC and mortality was significantly attenuated
after multivariable adjustment. This attenuation wasTable 4 Relationship between x-ray variables and death
(n = 824) – Univariate analyses
Variables Hazard ratio [95% CI] Model p Model AUROC [95% CI]
Model 1 <0.001 0.60 [0.55, 0.65]
CTR 1.78 [1.40, 2.27]
Model 2 <0.001 0.63 [0.58, 0.68]
AAC -
0 referent
1 2.43 [1.64, 3.61]
2 2.22 [1.41, 3.49]
3 4.35 [2.48, 7.66]
Model 3 <0.001 0.65 [0.60, 0.70]
CTR 1.52 [1.17, 1.97] 0.002
AAC <0.001
0 referent
1 2.16 [1.45, 3.24]
2 1.81 [1.13, 2.89]
3 3.49 [1.17, 1.97]
CTR = Cardiothoracic ratio; AAC = Aortic arch calcification score; AUROC = area
under the receiving operator curve.largely accounted for by confounding with age, as shown
in Table 6.
The predictive ability of CTR and AAC in addition to
our base predictive model for mortality is presented in
Table 5. As above, CTR was independently associated
with mortality when added to a best base model comprised
of the variables age at chest X-ray, sex, duration of
hemodialysis, race, diabetes, heart failure, ischemic heart
disease, baseline serum creatinine and serum phosphate
(predictors of survival in a base Cox model). However,
CTR did not significantly increase the c-statistic (i.e. area
under the curve of the base model) (0.71 [0.66, 0.76] vs.
0.71 [0.66, 0.76]). Furthermore, it did not improve the IDI
(IDI =0) or the net reclassification performance (NRI = 0).
Similarly, the addition of AAC to the base model did not
improve the IDI or NRI values (see Table 5).
Discussion
In our study of 824 prevalent patients on hemodialysis,
simple measures of cardiovascular risk on plain film
chest x-ray (CTR and AAC) did not improve prediction
of mortality. While CTR was independently associated
with mortality in multivariable survival analysis, it did
not consistently improve prediction of mortality risk.
Similarly, AAC was associated with mortality after ad-
justment for potential confounders, but the association
was significantly reduced after adjusting for age, and
prediction of mortality was not improved. Thus our
results do not support the utility of x-ray measures of
CTR and AAC for the purpose of predicting mortality in
a prevalent hemodialysis cohort.
Previous studies in non-ESRD patients have shown
that extent of vascular calcification reported from a
chest X-ray is strongly associated with mortality, cardiac
events, as well as coronary, abdominal aortic, and other
vascular calcification [12,15]. Furthermore, vascular cal-
cification beyond the thoracic aorta has been shown to
be associated with mortality in ESRD patients [12,24].
Using the grading system described previously, AAC
detectable on chest X-ray has been shown to be a strong
Table 5 Multivariable analysis (n = 824)
Model and variables Hazard ratio [95% CI] P value Model AUROC [95% CI]
Base model (BBM) Model P < 0.01 0.71 [0.66, 0.76]
Age at chest x-ray (per year) 1.05 [1.03, 1.06] <0.01
Sex 0.91 [0.62, 1.30] 0.62
Duration of hemodialysis (per year) 0.98 [0.91, 1.01] 0.53
Race <0.01
Caucasian 1.63 [0.90, 2.90] 0.11
Aboriginal 2.9 [1.5, 5.4] <0.01
Other referent -
Diabetes 0.71 [0.47, 1.07] 0.10
Heart failure 1.48 [0.92, 2.39] 0.10
Ischemic heart disease 1 [0.61, 1.64] 1.00
Creatinine (per 100 mcmol/L) 1.00 [1.00, 1.00] 0.15
Phosphate (per mcm/L) 1.0 [0.99, 1.00] 0.38
Base model + CTR Model P < 0.01 0.71 [0.66, 0.76]
Age at chest x-ray 1.04 [1.03, 1.05] <0.01
Sex 1.04 [0.73, 1.45] 0.82
Duration of hemodialysis 0.97 [0.91, 1.03] 0.33
Race 0.04
Caucasian 1.53 [0.89, 2.62] 0.13
Aboriginal 2.03 [1.16, 3.56] 0.01
Other referent -
Diabetes 0.83 [0.57, 1.20] 0.31
Heart failure 1.36 [0.91, 2.05] 0.14
Ischemic heart disease 0.94 [0.60, 1.46] 0.77
Creatinine 1.00 [1.00, 1.00] 0.14
Phosphate 1.00 [0.99, 1.00] 0.35
CTR 1.46 [1.11, 1.92] <0.01
Best base model + AAC Model P < 0.01 0.72 [0.67, 0.76]
Age at chest x-ray 1.04 [1.02, 1.05] <0.01
Sex 0.97 [0.69, 1.36] 0.86
Duration of hemodialysis 0.95 [0.89,1.02] 0.14
Race 0.02
Caucasian 1.44 [0.84, 2.46] 0.19
Aboriginal 2.11 [1.20, 3.73] 0.01
Other referent -
Diabetes 0.82 [0.57, 1.19] 0.29
Heart failure 1.47 [0.97, 2.21] 0.07
Ischemic heart disease 0.85 [0.54, 1.34] 0.48
Creatinine 1.00 [1.00, 1.00] 0.14
Phosphate 1.00 [0.99, 1.00] 0.33
AAC 0.03
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Table 5 Multivariable analysis (n = 824) (Continued)
0 referent
1 1.52 [0.99, 2.34] 0.06
2 1.22 [0.72, 2.05] 0.47
3 2.49 [1.28, 4.82] 0.01
CTR = Cardiothoracic ratio; AAC = Aortic arch calcification score; AUROC = area under the receiving operator curve.
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itional risk factors [14]. In a study of 401 incident
patients on dialysis in Japan, only a borderline significant
association between AAC and CV mortality (but not all
cause mortality) was identified [25]. While our study
found broadly similar results, we examined all cause
mortality in a prevalent cohort with a larger sample size.
Moreover, our study formally assessed the ability of
AAC to improve the accuracy of a predictive model
incorporating standard clinical variables. Statistical sig-
nificance in a multivariable model does not automa-
tically guarantee improvements in discrimination and
reclassification compared to standard clinical variables
alone, a point well illustrated by our results. Although
AAC remained statistically significant after multivariable
adjustment, addition of AAC to a base clinical model
did not significantly improve prediction. Finally, we
observed that AAC was strongly confounded by age. Ad-
justment for age was responsible for most of the atte-
nuation of the association between AAC and death in
the multivariable models (Tables 5 and 6).
Evidence in the general population supports CTR as a
predictor of mortality. A high CTR is an indicator of an
enlarged heart and is a predictor of poor outcome in heart
failure patients [16-18]. In the ESRD population, the
evidence is less clear. In a study of 468 hemodialysis
patients in Taiwan, CTR predicted both all-cause and CV
mortality at 2-years [26]. While our results also showed an
independent association between CTR and all cause mor-
tality on multivariable analysis, we additionally examined
whether CTR could improve the discrimination and re-
classification of a base clinical prediction model. As with
our analysis of AAC, we were unable to show improved
prediction for all-cause mortality (IDI and NRI = 0).Table 6 Analysis of confounding: the impact of AAC is drama
Variable Unadjusted hazard ratio P value Age-adjusted ha
AAC <0.001
0 referent referen
1 2.43 [1.64, 3.61] 1.52 [0.99,
2 2.22 [1.41, 3.49] 1.15 [0.69,
3 4.35 [2.48, 7.66] 2.00 [1.07,
*Adjusted for all variables in the best base model: age at x-ray, race, sex, duration o
phosphate, and serum creatinine at initiation of dialysis.Strengths of the study include it’s cohort design, large
sample size, and analytic strategy. The prospect of a
simple, inexpensive, routine imaging modality held
promise as a cheap method of risk assessment. Our
study population was unique in its size, its large aborigi-
nal representation, and that all patients received dialysis
through a unified program (Manitoba Renal Program).
Another strength was the independent review process
for CTR and AAC. Taking the mean of two independent
CTR measurements per X-ray ensured precision, while
settling all AAC discrepancies by consensus achieved the
same result.
Our study also has several limitations that must be
kept in mind when interpreting the results. First, our
study had high rate of exclusions due to absent x-rays.
These exclusions are partly explained by the fact that
patients without a chest X-ray were more likely to
receive dialysis in a rural, satellite setting, where acquisi-
tion of a chest X-ray is improbable in the context of
this study. Nevertheless, by analyzing a non-random
subset (i.e. patients with available x-rays) of younger
patients with a lower rate of IHD, we may have under-
estimated the true association between CTR/AAC and
mortality.
Second, the historical nature of our cohort imposes
additional limitations. Our database did not include
information on cause specific mortality. As CTR and
AAC are causally associated with CV causes of death,
using all cause mortality rather than CV mortality as the
outcome could have weakened the observed association
between these variables and outcome. On the other
hand, from a clinical perspective, all cause mortality is
the outcome of most relevance to clinicians and patients.
Even had we been able to demonstrate a predictive valuetically reduced by adjustment for age and other variables
zard ratio P value Fully adjusted hazard ratio* P value
0.06 0.03
t referent
2.33] 1.52 [0.99, 2.34]
1.92] 1.22 [0.72, 2.05]
3.75] 2.49 [1.28, 4.82]
f dialysis, diabetic status, history of heart failure, ischemic heart disease, serum
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findings would have been attenuated in the absence of a
demonstrated predictive value for all cause death. Third,
we were unable to ascertain the timing of x-rays in
relation to a dialysis run or to dry weight. The CTRs
measured therefore represent a combination of volume
expansion and LV mass. However, as both volume
overload and LV mass are associated with death, it is
unlikely that this confounding attenuated the observed
association between CTR and death. Finally, since we
analyzed a prevalent cohort, a survivor bias may be
present which may additionally have attenuated the risk
factor-outcome associations.
Conclusions
In summary, our data do not support the clinical utility
of simple plain X-ray measures of cardiac size and vas-
cular calcification for the purpose of mortality prediction
in maintenance hemodialysis patients. More advanced
imaging techniques such as cardiac MRI and coronary
CT may be needed to improve mortality prediction in
this population.
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